Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 182 clinical trials
Venetoclax + Decitabine vs. "7+3" Induction Chemotherapy in Young AML

This research is being done to assess the therapeutic efficacy and safety of a promising (venetoclax and decitabine) versus conventional "7+3"chemotherapy in induction young patients with acute

  • 0 views
  • 13 Mar, 2022
  • 1 location
Study of Enasidenib and Venetoclax in IDH2-Mutated Blood Cancers

The purpose of this research study is to see how safe and tolerable, and to find the highest or best dose, of an investigational combination of drugs called enasidenib and venetoclax, in

lymphoma
myelodysplastic syndromes
IDH2
induction chemotherapy
cancer
  • 0 views
  • 06 Dec, 2021
  • 2 locations
Loncastuximab Tesirine and Venetoclax for Relapsed/ Refractory Non-Hodgkin Lymphoma

The purpose of this study is to determine the correct dose and safety of combining two new cancer drugs, loncastuximab tesirine and venetoclax, as a treatment for relapsed or refractory B cell

  • 0 views
  • 05 Jun, 2022
  • 1 location
Acalabrutinib, Venetoclax, and Obinutuzumab for Initial Therapy of CLL (AVO)

This research study is evaluating the combination of three drugs - acalabrutinib, venetoclax, and obinutuzumab -- as a possible treatment for chronic lymphocytic leukemia (CLL). The drugs

direct bilirubin
rituximab
acalabrutinib
lymphadenopathy
chronic lymphocytic leukemia
  • 233 views
  • 19 Jun, 2022
  • 3 locations
A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL

This is an open-label, multicenter, Phase II study to investigate the efficacy and safety of venetoclax in combination with Rituximab/hyaluronidase human in participants with relapsed or

lymphoma
chronic lymphocytic leukemia refractory
rituximab
platelet count
lymphoid leukemia
  • 7 views
  • 28 Feb, 2022
  • 2 locations
Venetoclax Add in Combination With Fludarabine, Cyratabine and Idarubicine in Induction for Acute Myelid Leukemia (V-FIRST)

This study will test the effectiveness and safety of Venetoclax in combination with standard induction regimen for patients with acute leukemia and poor prognosis.

acute leukemia
idarubicin
fludarabine
venetoclax
  • 2 views
  • 12 Mar, 2022
  • 13 locations
Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS

This research study is assessing a new drug, duvelisib, in combination with a drug that is already FDA approved, venetoclax, as a possible treatment for participants with CLL or those with

lymphoma
chronic lymphocytic leukemia refractory
richter syndrome
platelet count
lymphoid leukemia
  • 21 views
  • 05 Mar, 2022
  • 6 locations
Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia

This phase II trial studies how well venetoclax, cladribine, low dose cytarabine, and azacitidine work in treating patients with acute myeloid leukemia that has previously not been treated

tretinoin
hematopoietic growth factors
hydroxyurea
neoadjuvant therapy
cytarabine
  • 19 views
  • 22 Mar, 2022
  • 1 location
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL

This research study is studying a medication called Venetoclax and a chemotherapy regimen as a possible treatment for Acute Lymphoblastic Leukemia. The drugs involved in this study are

methotrexate
cytarabine
dexamethasone
lymphoid leukemia
cancer
  • 3 views
  • 01 Feb, 2022
  • 2 locations
Venetoclax and Azacitidine for Non-Elderly Adult Patients With Acute Myeloid Leukemia

This study aims to treat non-elderly adult patients, who were previously untreated for acute myeloid leukemia, using venetoclax and azacitidine.

azacitidine
venetoclax
gilbert's syndrome
  • 7 views
  • 15 Mar, 2022
  • 1 location